BeyondSpring Inc. (BYSI)
Last updated: 2026-10-23 10:30:40. Prices reflect the latest pre-market trading data. Stock price data is sourced from Massive.
Summary
BeyondSpring Inc. (BYSI) operates in the PHARMACEUTICAL PREPARATIONS sector and is listed on NASDAQ. The stock is currently priced at $0.44, with a market capitalization of $20.39M and a P/E ratio of --. Over the past 52 weeks, its price has ranged from $0.42 to $2.44. This page covers its latest market performance, valuation, price trends and company information.
Key Market Data
$20.39M | |
$0.51 | |
$48.49 | |
$0.42 | |
$0.50 | |
71.85K | |
871.42K | |
-- | |
$2.44 | |
$0.42 | |
-- | |
-- |
BeyondSpring Inc. (BYSI) Pre-Market Stock Price
BeyondSpring Inc. (BYSI) is trading at $0.51 in pre-market trading as of 2026-10-22 23:31:00, up 2.84% ($0.01) from the previous close of $0.50
Pre-market trading shows how investors are pricing BYSI before the regular session opens. The current pre-market price is above the previous close, indicating positive early trading sentiment.
BeyondSpring Inc. (BYSI) 7-Day Stock Price Change
Over the past seven days, BeyondSpring Inc. (BYSI) moved from $0.59 to $0.44, representing a decline of 24.36% ($0.14).
The stock traded between $0.42 and $0.64 during the period. The latest price is near the lower end of the 7-day range, indicating strong downward.
The average daily volume was 42.55 thousand shares, down versus the previous seven-day period, indicating lower trading activity.
BYSI 52-Week Price Position
Position in Range: 1.1%
BYSI is currently trading at $0.44, placing it 1.1% of the way from its 52-week low of $0.42 to its 52-week high of $2.44. This percentage reflects the stock's relative position within its 52-week trading range, not its valuation or future performance.
What is BeyondSpring Inc. (BYSI)?
BeyondSpring Inc is engaged in clinical-stage biopharmaceutical activities focused on the development of cancer therapies. It is also focused on including immuno-oncology agents. It operates in Plinabulin pipeline segment. Its first asset, Plinabulin is a novel brain-penetrant microtubule modulator with dendritic cell maturation and vasculature modulation mechanism, which has the potential to help mitigate acquired resistance from prior immune checkpoint inhibitors (ICI) treatment in cancer patients. It is a Selective Immunomodulating Microtubule-Binding Agent (SIMBA), which may provide multiple therapeutic opportunities.
BeyondSpring Inc. Information
| Industry | PHARMACEUTICAL PREPARATIONS |
| Employees | 44 |
| Exchange | NASDAQ |
| Company Website |
How to Buy BeyondSpring Inc. (BYSI) Stock on MEXC
Eligible investors can buy real shares of BeyondSpring Inc. (BYSI) through MEXC RealStocks. Follow these three steps to open a RealStocks account, transfer USDT, and place a US stock order.
Frequently Asked Questions (FAQ)
1.What is BeyondSpring Inc. (BYSI) stock price today?
2.Is BYSI stock going up or down today?
3.What is BYSI pre-market price?
4.What is BYSI after-hours price?
5.Is BYSI stock trading now?
6.Where does BYSI sit relative to its 52-week high and low?
7.What sector is BeyondSpring Inc. in?
8.What is BeyondSpring Inc.'s market capitalization and where is it listed?
9.How is BYSI valued in terms of P/E ratio and EPS?
10.Does BeyondSpring Inc. pay a dividend?
Explore More US Stocks
Search Stocks
BYSI Stock Calculator
Estimate the value between BYSI shares and USD.
BYSI Shares to USD
1.00 BYSI shares = 0.444 USD
Calculations are estimates based on the latest available price and are for reference only.


